-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 HmrmRGffyX7FeRiHdSLpSutM2U4E6jSBpCe/aR5FetlSX6OC/cSN5AslDPo/H+YY
 GMqdBCjOY51MjdtpMv6u0Q==

<SEC-DOCUMENT>0000950134-99-003044.txt : 19990419
<SEC-HEADER>0000950134-99-003044.hdr.sgml : 19990419
ACCESSION NUMBER:		0000950134-99-003044
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	19990402
ITEM INFORMATION:		
FILED AS OF DATE:		19990416

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AMARILLO BIOSCIENCES INC
		CENTRAL INDEX KEY:			0001014763
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				751974352
		STATE OF INCORPORATION:			TX
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		
		SEC FILE NUMBER:	000-20791
		FILM NUMBER:		99595978

	BUSINESS ADDRESS:	
		STREET 1:		800 W 9TH AVE
		CITY:			AMARILLO
		STATE:			TX
		ZIP:			79101-3206
		BUSINESS PHONE:		8063761741

	MAIL ADDRESS:	
		STREET 1:		AMARILLO BIOSCIENCES INC
		STREET 2:		800 W 9TH AVE
		CITY:			AMARILLO
		STATE:			TX
		ZIP:			79101-3206
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<DESCRIPTION>FORM 8-K
<TEXT>

<PAGE>   1

                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                    FORM 8-K

                 CURRENT REPORT PURSUANT TO SECTION 13 OR 14(d)
                     OF THE SECURITIES EXCHANGE ACT OF 1934

                          CONVERSION OF DEBT TO EQUITY

DATE OF REPORT:  April 2, 1999

EXACT NAME OF REGISTRANT:  AMARILLO BIOSCIENCES, INC. ("Issuer")

STATE OR OTHER JURISDICTION OF INCORPORATION:  Texas

COMMISSION FILE NUMBER:  0-20791

IRS EMPLOYER IDENTIFICATION NUMBER:  75-1974352

ADDRESS OF PRINCIPAL EXECUTIVE OFFICES:  800 W. 9th, Amarillo, Texas 79101

REGISTRANT'S TELEPHONE NUMBER:  806/376-1741

ITEM 5:

                  On April 2, 1999, Issuer issued to HAYASHIBARA BIOCHEMICAL
LABORATORIES, INC., a Japanese corporation ("HBL"), 946,094 shares of Issuer's
common stock, par $.01. In exchange, HBL released a debt owed to it by Issuer
in the amount of $2,837,526.00.

                  Prior to the reported transaction, HBL owned 1,232,856 shares
out of 5,414,232 outstanding, for an ownership share of 22.8%. In the
transaction, HBL acquired 946,094 shares. Therefore, HBL now owns 2,178,950
shares out of 6,360,326 outstanding, for an ownership share of 34.3%.

                  The purpose of this transaction was to eliminate Issuer's
expense from interest on the debt owed to HBL. Eliminating this interest expense
will assist Issuer in remaining financially viable until it can complete its
research and become profitable.




<PAGE>   2



                                   SIGNATURES

                  Pursuant to the requirements of the Securities Exchange Act
of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.

                  Date: April 16, 1999.

                                           AMARILLO BIOSCIENCES, INC.


                                           By: /s/ EDWARD L. MORRIS
                                              ----------------------------------
                                              Edward L. Morris, Secretary
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
